New business models for antibiotic innovation

The increase in antibiotic resistance and the dearth of novel antibiotics have become a growing concern among policy-makers. A combination of financial, scientific, and regulatory challenges poses barriers to antibiotic innovation. However, each of these three challenges provides an opportunity to d...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Anthony D., Shah, Tejen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034556/
https://www.ncbi.nlm.nih.gov/pubmed/24646116
http://dx.doi.org/10.3109/03009734.2014.898717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034556/
https://www.ncbi.nlm.nih.gov/pubmed/24646116
http://dx.doi.org/10.3109/03009734.2014.898717

Ejemplares similares